LOGIN
High-dose TXA more effective than low-dose TXA and placebo for reducing blood loss in PLIF
March 2018
High-dose TXA more effective than low-dose TXA and placebo for reducing blood loss in PLIF
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:N/A
The effectiveness of low-dose and high-dose tranexamic acid in posterior lumbar interbody fusion: a double-blinded, placebo-controlled randomized study
Eur Spine J. 2017 Nov;26(11):2851-2857Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
72 patients scheduled for posterior lumbar interbody fusion were randomized to either high-dose tranexamic acid, low-dose tranexamic acid, or placebo saline. All patients were treated with an initial bolus prior to incision, followed by continuous infusion for the next 5 hours. Main outcome measures included intraoperative, postoperative, and total blood loss, as well as transfusion rate. Measures...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.